AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12734746
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone therapy (GH) at a dosage of 28 IU/m² per week for 4 years
Trial: 10374214
Drug: 2.5 mg/day
RxNorm normalized name: Androderm 2.5 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/day tibolone continuously (n = 27; group T)
Trial: 10374214
Drug: 0.625 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg/day conjugated equine estrogen plus 2.5 mg/day of medroxyprogesterone (n = 25; group E-P)
Trial: 10374214
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (n = 24; group C)
Trial: 2071784
Drug: Standardized orchard
RxNorm normalized name: Standardized orchard grass pollen
DrugBank: Dactylis glomerata pollen (DB10379)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized orchard grass-pollen extract or standardized mixed-pollen extract (specific immunotherapy)
Trial: 25471256
Drug: Vestibular rehabilitation
RxNorm normalized name: Recombinant Vesicular Stomatitis Virus (rVSV) strain Indiana with a deletion of the VSV envelope glycoprotein (G) replaced with the Zaire Ebola Virus (ZEBOV) Kikwit 1995 strain surface glycoprotein (GP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vestibular rehabilitation (group-based sessions conducted twice a week for 9 weeks)
Trial: 22009807
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl 1µg/kg administered three minutes before anesthesia induction
Trial: 22009807
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl 1µg/kg
Trial: 19147455
Drug: Strict metabolic
RxNorm normalized name: Euphrasia stricta extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strict metabolic control by insulin (I-group; n = 21)
Trial: 19147455
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose lowering agents (O-group; n = 18)
Trial: 15150623
Drug: Epidoxorubicin (E)
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidoxorubicin (E) 80 mg/m² + Paclitaxel (T) 175 mg/m² (3 h infusion), every 21 days for 4-6 cycles
Trial: 15150623
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m² (3 h infusion), every 21 days for 4-6 cycles
Trial: 7902200
Drug: Neuroleptic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic treatment teaching module applied three hours per week for two to three months
Trial: 7902200
Drug: Neuroleptic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic treatment teaching module
Trial: 25794779
Drug: Amoxicillin (or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (or clindamycin) given from one hour before operation until 3 days postoperatively
Trial: 25794779
Drug: Placebo given
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo given at the same time as the antibiotic
Trial: 15126920
Drug: Oral methionine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral methionine (100 mg/kg)
Trial: 20396717
Drug: nonsteroidal antiinflammatory
RxNorm normalized name: Arthriten Inflammatory Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nonsteroidal antiinflammatory preparations (NSAIDs)
Trial: 11434828
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg/d (secondary prevention cohort)
Trial: 31965772
Drug: Famciclovir 500
RxNorm normalized name: famciclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 500 mg
Trial: 2337520
Drug: Topical 0.05%
RxNorm normalized name: ingenol topical 0.05% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.05% tretinoin
Trial: 9519139
Drug: Placebo base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo base cream
Trial: 504666
Drug: 10 mg/50
RxNorm normalized name: Nipride RTU, 10 mg/50 mL-NaCl 0.9% intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/50 ml of Xylocaine
Trial: 504666
Drug: 20 mg/50
RxNorm normalized name: Pepcid, 20 mg/50 mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/50 ml of Xylocaine
Trial: 23437789
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day of red grape seed extract (RGSE)
Trial: 19909499
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (one gram twice daily)
Trial: 14644401
Drug: Insulin resistant
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin resistant subjects (IR)
Trial: 14644401
Drug: Insulin sensitive
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin sensitive subjects (Control)
Trial: 6654626
Drug: Antacids plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacids plus vitamin A (3 X 50,000 U orally)
Trial: 6654626
Drug: Antacids plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacids plus vitamin A plus cyproheptadine (3 X 4 mg orally)
Trial: 6654626
Drug: Antacids only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacids only
Trial: 3511867
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CAT scans and biochemical tests
Trial: 24925372
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg enoxaparin subcutaneously once daily
Trial: 24925372
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg enoxaparin subcutaneously once daily
Trial: 19449224
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF) nasal spray, 200 microg for 3 months
Trial: 15632339
Drug: Lowest quartile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowest quartile of control PIGF concentrations (<118 pg/mL)
Trial: 12745724
Drug: Oral ephedrine
RxNorm normalized name: ephedrine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ephedrine 50 mg
Trial: 12745724
Drug: Supplemental ephedrine
RxNorm normalized name: Ephedrine
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supplemental ephedrine (3 mg)
Trial: 11206014
Drug: Pharmacologic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic therapy to passivate plaque for at least 24 hours
Trial: 11206014
Drug: Low-molecular-weight heparins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors
Trial: 8645662
Drug: Soluble ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble ibuprofen 200 mg
Trial: 8645662
Drug: Soluble ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble ibuprofen 600 mg
Trial: 8645662
Drug: Ibuprofen tablets
RxNorm normalized name: Ibuprofen Tablets
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen tablets 200 mg
Trial: 1346564
Drug: Clonidine, 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine, 0.075 mg orally, at baseline and after 2 hours if heart rate did not decrease by at least 20%
Trial: 2719902
Drug: Cimetidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (200 mg three times daily and 400 mg at night)
Trial: 28556506
Drug: Fosdagrocorat 10
RxNorm normalized name: Fosdagrocorat
DrugBank: Fosdagrocorat (DB12198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosdagrocorat 10 mg
Trial: 28556506
Drug: Fosdagrocorat 15
RxNorm normalized name: Fosdagrocorat
DrugBank: Fosdagrocorat (DB12198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosdagrocorat 15 mg
Trial: 31168411
Drug: Fosdagrocorat 1
RxNorm normalized name: Fosdagrocorat
DrugBank: Fosdagrocorat (DB12198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosdagrocorat 1 mg, 5 mg, 10 mg
Trial: 31168411
Drug: Fosdagrocorat 1
RxNorm normalized name: Fosdagrocorat
DrugBank: Fosdagrocorat (DB12198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosdagrocorat 1 mg, 5 mg, 10 mg, 15 mg
Trial: 28556506
Drug: Prednisone 10
RxNorm normalized name: prednisone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 10 mg
Trial: 28556506
Drug: Prednisone 5
RxNorm normalized name: prednisone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 5 mg
Trial: 22365462
Drug: Cool Teens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cool Teens program (12-week computerized cognitive-behavioral therapy program for anxiety management)
Trial: 19481279
Drug: Simvastatin (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (low dose: 5 mg)
Trial: 19481279
Drug: Simvastatin (moderate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (moderate dose: 10 mg)
Trial: 16177674
Drug: Rate control
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rate control (Digoxin and beta-blocker)
Trial: 16177674
Drug: Long-term oral
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term oral anticoagulation
Trial: 8843283
Drug: Crystalline formulation
RxNorm normalized name: Mesembryanthemum crystallinum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalline formulation of erythromycin ethylsuccinate (CEE) at 1,000 mg every 12 h
Trial: 8843283
Drug: Amorphous formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amorphous formulation of erythromycin ethylsuccinate (AEE) at 500 mg every 12 h
Trial: 6233398
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg intramuscular (IM) MPA (high dose) daily for four weeks
Trial: 6233398
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg IM MPA (low dose) twice weekly for four weeks
Trial: 24272917
Drug: Romosozumab 1
RxNorm normalized name: romosozumab 105 mg/1.17 mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Romosozumab 1 mg/kg Q2W
Trial: 24272917
Drug: Romosozumab 2
RxNorm normalized name: ROMOSOZUMAB
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Romosozumab 2 mg/kg Q2W
Trial: 24272917
Drug: Romosozumab 2
RxNorm normalized name: ROMOSOZUMAB
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Romosozumab 2 mg/kg Q4W
Trial: 24272917
Drug: Romosozumab 3
RxNorm normalized name: ROMOSOZUMAB
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Romosozumab 3 mg/kg Q4W
Trial: 18574390
Drug: Trimetazidine (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMZ) 20 mg tid for 3 months (n = 19)
Trial: 7778179
Drug: Theophylline (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (600 mg/day in 2 doses)
Trial: 2190460
Drug: Isosorbide-5-mononitrate, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate, 20 mg 3 times daily
Trial: 358755
Drug: Chlorpromazine (CPZ)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ) 200 mg
Trial: 358755
Drug: Chlorpromazine (CPZ)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ) 400 mg
Trial: 358755
Drug: Chlorpromazine (CPZ)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ) 600 mg
Trial: 28072709
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) - bolus dose of 30 mg/kg i.v, maintenance dosage of 2 mg/kg/h
Trial: 19796051
Drug: Sildenafil (25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (25, 50, or 100 mg)
Trial: 17063108
Drug: Topical pharyngeal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical pharyngeal anesthesia with lidocaine throat spray
Trial: 17063108
Drug: Placebo sedation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo sedation and placebo throat spray
Trial: 19231302
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous cannula nor throat spray (control group)
Trial: 9385861
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg bd for 3 months
Trial: 7974316
Drug: Oxygen at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen at 2 l/min via a mask
Trial: 7974316
Drug: Control walk
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control walk using a sham circuit (breathing air via an oxygen mask at 2 l/min from an unlabelled cylinder)
Trial: 6990875
Drug: Aerosol administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosol administration of fenoterol
Trial: 1162529
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of fenoterol
Trial: 30741567
Drug: Crocus sativus
RxNorm normalized name: CROCUS SATIVUS WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crocus sativus (saffron) 20-30 mg/d (20 mg/d for <30 kg and 30 mg/d for >30 kg)
Trial: 30741567
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 20-30 mg/d (20 mg/d for <30 kg and 30 mg/d for >30 kg)
Trial: 23630039
Drug: Beta-alanine (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-alanine (80 mg·kg‐1BM·day‐1)
Trial: 19743907
Drug: Unemployed, currently
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unemployed, currently unmarried, obese, never pregnant, and ever use of oral contraceptive
Trial: 9193433
Drug: Low-dose ramipril
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ramipril (0.625 mg)
Trial: 11174337
Drug: Full-dose ramipril
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full-dose ramipril (10 mg)
Trial: 3890604
Drug: Morphine (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (standard analgesic)
Trial: 30170533
Drug: Vaginal gels
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal gels
Trial: 30170533
Drug: Monthly product
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly product use
Trial: 26872219
Drug: Misoprostol treatment
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol treatment by midwives
Trial: 26872219
Drug: Misoprostol treatment
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol treatment by physicians
Trial: 23225854
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of borneol (30.0 mg/kg)
Trial: 23225854
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of borneol (30.0 mg/kg)
Trial: 23225854
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of borneol (30.0 mg/kg)
Trial: 18801829
Drug: Intranasally administered
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasally administered oxytocin (24 UI)
Trial: 16035378
Drug: Amoxicillin 875
RxNorm normalized name: amoxicillin 875 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 875 mg tablets (test formulation)
Trial: 16035378
Drug: Amoxil BD
RxNorm normalized name: Amoxi Drop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxil BD 875 mg tablets (reference formulation)
Trial: 27928851
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg intravenous parecoxib
Trial: 18203048
Drug: Amisulpride 400
RxNorm normalized name: amisulpride 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 400 mg/day
Trial: 9298518
Drug: Amisulpride 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 800 mg/day
Trial: 9696517
Drug: Amisulpride 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 1200 mg/day
Trial: 9167505
Drug: Haloperidol 16
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol 16 mg/day
Trial: 7654731
Drug: Lovastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (10 mg/day)
Trial: 11545549
Drug: Bezafibrate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate (400 mg/day)
Trial: 2127139
Drug: n-3 PUFA-rich
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA-rich fish oil diet (2 g/day)
Trial: 2127139
Drug: n-3 PUFA-rich
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA-rich fish oil diet (6 g/day)
Trial: 371629
Drug: Aspirin (3904
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (3904 mg daily for 1 week)
Trial: 371629
Drug: Fenoprofen (2400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoprofen (2400 mg daily for 1 week)
Trial: 26032729
Drug: Tailored delirium
RxNorm normalized name: Octinoxate 0.068 g in 1 g TOPICAL PASTE [Esika PRO HD LONGWEAR LONG-LASTING HIGH-DEFINITION COLOR SPF 20 FUCSIA DELIRIO - PINK]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored delirium prevention protocol applied daily for the first 7 days of ICU hospitalization
Trial: 27683610
Drug: Inhaled treprostinil
RxNorm normalized name: treprostinil Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled treprostinil
Trial: 19691461
Drug: Other antiviral
RxNorm normalized name: Other antivirals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antiviral agents
Trial: 19691461
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of shingles
Trial: 19691461
Drug: Different classes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different classes of drugs for post-herpetic neuralgia
Trial: 3145357
Drug: VACA chemotherapy
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VACA chemotherapy (vincristine, actinomycin D, cyclophosphamide, and adriamycin) with local control via surgery and/or radiation
Trial: 3145357
Drug: VAIA chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAIA chemotherapy (high doses of ifosfamide with mesna uroprotection)
Trial: 30566760
Drug: Curcumin (CUR)
DrugBank: Curcumin sulfate (DB14635)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (CUR) 180 mg/d for 7 days before exercise
Trial: 30566760
Drug: Curcumin (CUR)
DrugBank: Curcumin sulfate (DB14635)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (CUR) 180 mg/d for 7 days after exercise
Trial: 29092078
Drug: Sodium selenite
RxNorm normalized name: Sodium selenite
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Sodium selenite 300 µg/d po + Methimazole (MMI)
Trial: 23811682
Drug: Highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly purified eicosapentaenoic acid (EPA) 1,800 mg/day for 6 months
Trial: 20668324
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no EPA treatment)
Trial: 18199388
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (2.9 g n-3 LCPUFA/d)
Trial: 1676932
Drug: MK-458 (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-458 (up to 60 mg per day)
Trial: 30762806
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g single dose of azithromycin
Trial: 30762806
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg doxycycline twice daily for 7 days
Trial: 29180640
Drug: CSII combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSII combined with metformin therapy
Trial: 20740300
Drug: Axitinib (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Axitinib (5 mg oral dose) with ketoconazole (400 mg/day for 7 days)
Trial: 20740300
Drug: Axitinib (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Axitinib (5 mg oral dose) alone